Indications and Purposes
| 1. Indications And Usage Vyndaqel And Vyndamax Are Indicated For The Treatment Of The Cardiomyopathy Of Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis (Attr-Cm) In Adults To Reduce Cardiovascular Mortality And Cardiovascular-Related Hospitalization. Vyndaqel And Vyndamax Are Transthyretin Stabilizers Indicated For The Treatment Of The Cardiomyopathy Of Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis In Adults To Reduce Cardiovascular Mortality And Cardiovascular-Related Hospitalization. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Tafamidis Meglumine |
|
ZINC2020259 |